Drug Landscape ›
Fleet Enema ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 491
Most-reported reactions
Nausea — 62 reports (12.63%) Death — 59 reports (12.02%) Constipation — 54 reports (11%) Fatigue — 52 reports (10.59%) Vomiting — 51 reports (10.39%) Diarrhoea — 50 reports (10.18%) Dyspnoea — 46 reports (9.37%) Pain — 41 reports (8.35%) Pneumonia — 40 reports (8.15%) Asthenia — 36 reports (7.33%)
Source database →
Fleet Enema in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Fleet Enema approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Fleet Enema in United States?
Nova Scotia Health Authority is the originator. The local marketing authorisation holder may differ — check the official source linked above.